Literature DB >> 22267272

Indoor inhalation dose estimates due to radon and thoron in some areas of South-Western Punjab, India.

Sanjeev Kumar1, Surinder Singh, Bikramjit Singh Bajwa, Bhupinder Singh, Arvind D Sabharwal, K P Eappen.   

Abstract

LR-115 (type II)-based radon-thoron discriminating twin-chamber dosemeters have been used for estimating radon ((222)Rn) and thoron ((220)Rn) concentrations in dwellings of south-western Punjab, India. The present study region has shown pronounced cases of cancer incidents in the public [Thakur, Rao, Rajwanshi, Parwana and Kumar (Epidemiological study of high cancer among rural agricultural community of Punjab in Northern India. Int J Environ Res Public Health 2008; 5(5):399-407) and Kumar et al. (Risk assessment for natural uranium in subsurface water of Punjab state, India. Hum Ecol Risk Assess 2011;17:381-93)]. Radon being a carcinogen has been monitored in some dwellings selected randomly in the study area. Results show that the values of radon ((222)Rn)  varied from 21 to 79 Bq m(-3), with a geometric mean of 45 Bq m(-3) [geometric standard deviation (GSD 1.39)], and those of thoron ((220)Rn)  from minimum detection level to 58 Bq m(-3) with a geometric mean of 19 Bq m(-3) (GSD 1.88). Bare card data are used for computing the progeny concentration by deriving the equilibrium factor (F) using a root finding method [Mayya, Eappen and Nambi (Methodology for mixed field inhalation dosimetry in monazite areas using a twin-cup dosemeter with three track detectors. Radiat Prot Dosim 1998;77(3):177-84)]. Inhalation doses have been calculated and compared using UNSCEAR equilibrium factors and by using the calculated F-values. The results show satisfactory comparison between the values.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22267272     DOI: 10.1093/rpd/ncr461

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  1 in total

Review 1.  A review on natural background radiation.

Authors:  Daryoush Shahbazi-Gahrouei; Mehrdad Gholami; Samaneh Setayandeh
Journal:  Adv Biomed Res       Date:  2013-07-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.